1. Home
  2. ICG vs ALDX Comparison

ICG vs ALDX Comparison

Compare ICG & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intchains Group Limited

ICG

Intchains Group Limited

HOLD

Current Price

$1.38

Market Cap

80.1M

Sector

Technology

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$1.79

Market Cap

95.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICG
ALDX
Founded
2017
2004
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.1M
95.7M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
ICG
ALDX
Price
$1.38
$1.79
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$5.25
$5.50
AVG Volume (30 Days)
16.8K
6.0M
Earning Date
05-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$1.07
52 Week High
$3.22
$6.18

Technical Indicators

Market Signals
Indicator
ICG
ALDX
Relative Strength Index (RSI) 59.08 34.45
Support Level $1.13 $1.48
Resistance Level $1.93 $2.33
Average True Range (ATR) 0.11 0.14
MACD 0.03 0.12
Stochastic Oscillator 100.00 54.63

Price Performance

Historical Comparison
ICG
ALDX

About ICG Intchains Group Limited

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: